Biology subjects

Morel, N.

Publications and source records attributed to Morel, N..

4 recordsLinked to original sources

bioRxiv2026

Actin pool controls the scaling of dynamic actin networks

Scaling is a fundamental property of living systems, allowing cells to match the size of their internal components to their volume. The size and shape of cells depend largely on the actin cytoskeleton, whose dynamic self-assembling structures are central to this adaptation. Yet how they self-assemble in a volume-dependent manner remains unresolved. To address this question, we used a biomimetic system consisting of beads propelled by actin polymerization in microwells of different volumes, which allowed us to work with a limited and defined number of components. This approach enabled the first reconstitution, from purified proteins, of dynamic cytoskeletal structures that adapt to the volume of their environment. The scalability of these structures depends on how strongly they deplete monomers from a shared pool, and tuning the disassembly rate is sufficient to shift their scaling regime. Scaling principles also hold for multiple competing structures, with greater competition imposing stronger constraints on the monomer pool. Together, these results establish a mechanistic framework in which a structure's capacity to adapt is set by how much it draws down shared resources as it grows, a principle that may extend to other intracellular structures that scale with the cells that build them.

biochemistry↗

bioRxiv2026

Topographic reference modelling of white matter hyperintensities across the adult lifespan

White matter hyperintensities (WMH) are among the most common MRI findings in older adults. They are widely regarded as markers of brain aging and cerebral small-vessel disease, and associated with risk for cognitive decline, Alzheimers disease and related dementias (ADRD), and stroke. White matter hyperintensities (WMH) are typically interpreted by total lesion burden, but lesions with similar volumes can occupy different anatomical locations, potentially reflecting distinct pathological processes. Here we present voxelwise topographic reference modelling (vTRM), a framework for characterizing individual WMH masks against age- and sex-stratified frequency maps derived from cognitively unimpaired individuals. Using 42,469 FLAIR-derived lesion masks from twelve adult cohorts, we mapped population-level WMH spatial vulnerability, characterized age-related changes in its distribution across periventricular, lobar and arterial-territory compartments, and constructed paired percentile charts for lesion burden and spatial typicality. A quadrant-based classification defined by these two percentile dimensions revealed graded relationships with ADRD pathophysiology, neurodegeneration, and cognitive impairment, while identifying WMH patterns differentially associated with ageing-related, vascular and neurodegenerative processes among individuals with similar lesion volumes. These reference charts establish a benchmark for normative WMH ageing, enabling quantification of individual deviations from typical age-, sex- and burden-related patterns and identification of WMH phenotypes associated with vascular, neurodegenerative or mixed etiologies. The framework, together with a deployable 3D U-Net model trained on these data for automated WMH segmentation, is available through the Brain Lesion Analytics platform (https://brainlesionanalytics.org/).

neuroscience↗

bioRxiv2025

Entry, replication and innate immunity evasion of BANAL-236, a SARS-CoV-2-related bat virus, in Rhinolophus and human cells

Asian Rhinolophus bats are considered the natural reservoirs of an ancestral SARS-CoV-2. However, the biology of SARS-CoV-2-related viruses in bat cells is not well understood. Here, we investigated the replication of BANAL-236, the only bat-derived SARS-CoV-2 relative isolated to date, in Rhinolophus cells. BANAL-236 did not replicate in wild-type Rhinolophus cell lines. Entry assays using pseudoviruses expressing the spike proteins (S) of SARS-CoV-2, BANAL-236, and BANAL-52 revealed that efficient S-mediated entry depends on the expression of human ACE2 (hACE2) and human TMPRSS2 (hTMPRSS2) in human and Rhinolophus cells. Expression of Rhinolophus entry factors, either alone or in combination, did not facilitate SARS-CoV-2 or BANAL-236 entry in human cells, suggesting that the S protein of BANAL-236 interacts more efficiently with hACE2 than with its Rhinolophus counterpart (rACE2). Through biochemical, virological, and electron microscopy analyses, we showed that BANAL-236 and SARS-CoV-2 completed their replication cycles in a Rhinolophus cell line engineered to express high levels of hACE2 and hTMPRSS2. Despite efficient viral replication in modified Rhinolophus and human cells, no induction of interferon (IFN)-stimulated genes was detected. Using a screening approach, we identified several BANAL-236 proteins that antagonize IFN production and signaling in human cells. Our findings thus show that BANAL-236 possesses critical features that enabled zoonotic spillover: hACE2 usage and potent evasion of human IFN responses. The Rhinolophus cellular model we established offers a platform for further investigating the interactions between bat coronaviruses and their reservoir hosts. Author summaryBats are known reservoirs for viruses that cause severe diseases in humans, such as coronaviruses and filoviruses. Bat species naturally or experimentally infected with these viruses rarely exhibit clinical symptoms, suggesting an evolved tolerance to viral infections. To elucidate the mechanisms underlying viral tolerance and to identify factors that could facilitate zoonotic spillover, it is essential to study the replication of bat-borne viruses in relevant bat cellular models. Here, we investigated the replication of BANAL-236, a SARS-CoV-2 related virus isolated from fecal samples of Rhinolophus bats in Northen Laos, in a novel cell line derived from Rhinolophus ferrumequinum lung fibroblasts. Our findings reveal that BANAL-236 can efficiently use human entry factors and potently evade the human innate immune response, two traits that may have contributed to its zoonotic transmission. Furthermore, the R. ferrumequinum cell lines we developed is a valuable model for investigating the molecular interactions between sarbecoviruses and their natural hosts.

microbiology↗

bioRxiv2022

Resistance of Omicron subvariants BA.2.75.2, BA.4.6 and BQ.1.1 to neutralizing antibodies

Convergent evolution of SARS-CoV-2 Omicron BA.2, BA.4 and BA.5 lineages has led to the emergence of several new subvariants, including BA.2.75.2, BA.4.6. and BQ.1.1. The subvariants BA.2.75.2 and BQ.1.1 are expected to become predominant in many countries in November 2022. They carry an additional and often redundant set of mutations in the spike, likely responsible for increased transmissibility and immune evasion. Here, we established a viral amplification procedure to easily isolate Omicron strains. We examined their sensitivity to 6 therapeutic monoclonal antibodies (mAbs) and to 72 sera from Pfizer BNT162b2-vaccinated individuals, with or without BA.1/BA.2 or BA.5 breakthrough infection. Ronapreve (Casirivimab and Imdevimab) and Evusheld (Cilgavimab and Tixagevimab) lost any antiviral efficacy against BA.2.75.2 and BQ.1.1, whereas Xevudy (Sotrovimab) remained weakly active. BQ.1.1 was also resistant to Bebtelovimab. Neutralizing titers in triply vaccinated individuals were low to undetectable against BQ.1.1 and BA.2.75.2, 4 months after boosting. A BA.1/BA.2 breakthrough infection increased these titers, which remained about 18-fold lower against BA.2.75.2 and BQ.1.1, than against BA.1. Reciprocally, a BA.5 breakthrough infection increased more efficiently neutralization against BA.5 and BQ.1.1 than against BA.2.75.2. Thus, the evolution trajectory of novel Omicron subvariants facilitated their spread in immunized populations and raises concerns about the efficacy of most currently available mAbs.

microbiology↗